May 10, 2022 - Portal Instruments has been featured in Fierce Pharma. "Gerresheimer invests in Portal's needle-free drug delivery, teeing Takeda partner up to advance tech", showcases Gerresheimer's agreement with Portal to support the development of the needle-free drug delivery platform.
May 10, 2022 -Yesterday, Fierce Pharma published an article showcasing Gerresheimer's investment into Portal Instruments. The article titled, "Gerresheimer invests in Portal's needle-free drug delivery, teeing Takeda partner up to advance tech", showcases Gerresheimer's agreement with Portal to support the development of the needle-free drug delivery platform.
Read the full article here:
April 2021 - In the US, approximately 12% of women age 15 to 44 have trouble getting pregnant or carrying a pregnancy to term.¹ To honor National Infertility Week we sat down with Myra, an infertility nurse to talk about the hardships and joys associated with infertility treatment.
June 2021 - Needles are a 150-year-old technology. The world around us is rapidly evolving but drug delivery has not made the same technological strides that other medical devices have. Portal Instruments is looking to change that with a highly innovative needle-free drug delivery injector.
February 11, 2020 - Gerresheimer recently published an article describing Portal Instrument’s innovative primary drug container which is used in Portal’s needle-free drug delivery platform. Read the full pdf article here.
Please fill out the details below and we will get back to you shortly.